For example, doxorubicin induces extracellular matrix degradation, epithelial–mesenchymal transition, and tumor invasion via the regulation of MMP-2 and MMP-9 enzyme activity and TGFβ signaling activation [62,63] (Table 2). This evidence concerns the gene TGFB1 and neoplasm.